IRWD : Summary for Ironwood Pharmaceuticals, Inc. - Yahoo Finance

U.S. Markets closed

Ironwood Pharmaceuticals, Inc. (IRWD)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
15.51+0.30 (+1.97%)
At close: 4:00 PM EST
People also watch:
INFIAEGRRPTPSGYPANAC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close15.21
Open15.17
Bid7.03 x 100
Ask17.50 x 200
Day's Range14.98 - 15.74
52 Week Range7.35 - 16.89
Volume1,203,077
Avg. Volume1,394,512
Market Cap2.27B
Beta1.01
PE Ratio (TTM)-27.16
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Hedge Funds Are Buying Ironwood Pharmaceuticals, Inc. (IRWD)
    Insider Monkey4 days ago

    Hedge Funds Are Buying Ironwood Pharmaceuticals, Inc. (IRWD)

    At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]

  • Ironwood (IRWD) Presents Positive Phase III Data on Zurampic
    Zacks19 days ago

    Ironwood (IRWD) Presents Positive Phase III Data on Zurampic

    Ironwood Pharmaceuticals, Inc. (IRWD) presented efficacy and safety data from two phase III extension studies on its marketed drug Zurampic (lesinurad) at the American College of Rheumatology (ACR).

  • Capital Cube19 days ago

    ETFs with exposure to Ironwood Pharmaceuticals, Inc. : November 14, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)